INTUITIVE SURGICAL INC (1ISRG.MI) Stock Fundamental Analysis
Europe - Euronext Milan - BIT:1ISRG - US46120E6023 - Common Stock
461.35 EUR
+60.75 (+15.16%)
1ISRG gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 60 industry peers in the Health Care Equipment & Supplies industry. 1ISRG scores excellent points on both the profitability and health parts. This is a solid base for a good stock. 1ISRG is valued quite expensive, but it does show an excellent growth. With these ratings, 1ISRG could be worth investigating further for growth and quality investing!.
1. Profitability
1.1 Basic Checks
In the past year 1ISRG was profitable.
1ISRG had a positive operating cash flow in the past year.
In the past 5 years 1ISRG has always been profitable.
In the past 5 years 1ISRG always reported a positive cash flow from operatings.
1.2 Ratios
1ISRG has a Return On Assets of 14.19%. This is amongst the best in the industry. 1ISRG outperforms 91.67% of its industry peers.
The Return On Equity of 1ISRG (16.12%) is better than 81.67% of its industry peers.
Looking at the Return On Invested Capital, with a value of 12.45%, 1ISRG belongs to the top of the industry, outperforming 88.33% of the companies in the same industry.
Measured over the past 3 years, the Average Return On Invested Capital for 1ISRG is in line with the industry average of 8.99%.
The last Return On Invested Capital (12.45%) for 1ISRG is above the 3 year average (10.15%), which is a sign of increasing profitability.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.19% | ||
| ROE | 16.12% | ||
| ROIC | 12.45% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)10.15%
ROIC(5y)9.87%
1.3 Margins
1ISRG has a better Profit Margin (28.58%) than 96.67% of its industry peers.
In the last couple of years the Profit Margin of 1ISRG has declined.
1ISRG has a better Operating Margin (29.44%) than 100.00% of its industry peers.
In the last couple of years the Operating Margin of 1ISRG has declined.
1ISRG has a better Gross Margin (66.38%) than 75.00% of its industry peers.
1ISRG's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 29.44% | ||
| PM (TTM) | 28.58% | ||
| GM | 66.38% |
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
2. Health
2.1 Basic Checks
1ISRG has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
1ISRG has more shares outstanding than it did 1 year ago.
The number of shares outstanding for 1ISRG has been increased compared to 5 years ago.
There is no outstanding debt for 1ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
2.2 Solvency
There is no outstanding debt for 1ISRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | N/A |
ROIC/WACC1.42
WACC8.75%
2.3 Liquidity
A Current Ratio of 4.97 indicates that 1ISRG has no problem at all paying its short term obligations.
1ISRG has a Current ratio of 4.97. This is amongst the best in the industry. 1ISRG outperforms 96.67% of its industry peers.
A Quick Ratio of 4.20 indicates that 1ISRG has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 4.20, 1ISRG belongs to the best of the industry, outperforming 96.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.97 | ||
| Quick Ratio | 4.2 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 28.12% over the past year.
1ISRG shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.48% yearly.
Looking at the last year, 1ISRG shows a very strong growth in Revenue. The Revenue has grown by 22.18%.
Measured over the past years, 1ISRG shows a quite strong growth in Revenue. The Revenue has been growing by 13.27% on average per year.
EPS 1Y (TTM)28.12%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%30.43%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%22.91%
3.2 Future
The Earnings Per Share is expected to grow by 15.47% on average over the next years. This is quite good.
The Revenue is expected to grow by 14.12% on average over the next years. This is quite good.
EPS Next Y19.93%
EPS Next 2Y16.17%
EPS Next 3Y15.85%
EPS Next 5Y15.47%
Revenue Next Year21.17%
Revenue Next 2Y18.1%
Revenue Next 3Y16.53%
Revenue Next 5Y14.12%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 61.93, 1ISRG can be considered very expensive at the moment.
Compared to the rest of the industry, the Price/Earnings ratio of 1ISRG is on the same level as its industry peers.
The average S&P500 Price/Earnings ratio is at 25.45. 1ISRG is valued rather expensively when compared to this.
Based on the Price/Forward Earnings ratio of 53.92, the valuation of 1ISRG can be described as expensive.
Based on the Price/Forward Earnings ratio, 1ISRG is valued a bit more expensive than the industry average as 63.33% of the companies are valued more cheaply.
1ISRG is valuated expensively when we compare the Price/Forward Earnings ratio to 34.46, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 61.93 | ||
| Fwd PE | 53.92 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of 1ISRG indicates a slightly more expensive valuation: 1ISRG is more expensive than 63.33% of the companies listed in the same industry.
1ISRG's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 84.18 | ||
| EV/EBITDA | 52.99 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of 1ISRG may justify a higher PE ratio.
A more expensive valuation may be justified as 1ISRG's earnings are expected to grow with 15.85% in the coming years.
PEG (NY)3.11
PEG (5Y)5.39
EPS Next 2Y16.17%
EPS Next 3Y15.85%
5. Dividend
5.1 Amount
No dividends for 1ISRG!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
BIT:1ISRG (10/30/2025, 7:00:00 PM)
461.35
+60.75 (+15.16%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners88.66%
Inst Owner ChangeN/A
Ins Owners0.45%
Ins Owner ChangeN/A
Market Cap165.38B
Revenue(TTM)9.61B
Net Income(TTM)2.75B
Analysts78.54
Price Target521.28 (12.99%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.16%
Min EPS beat(2)11.61%
Max EPS beat(2)18.71%
EPS beat(4)4
Avg EPS beat(4)13.53%
Min EPS beat(4)3.05%
Max EPS beat(4)20.76%
EPS beat(8)8
Avg EPS beat(8)11%
EPS beat(12)11
Avg EPS beat(12)7.6%
EPS beat(16)13
Avg EPS beat(16)5.75%
Revenue beat(2)2
Avg Revenue beat(2)2%
Min Revenue beat(2)1.84%
Max Revenue beat(2)2.17%
Revenue beat(4)4
Avg Revenue beat(4)2.55%
Min Revenue beat(4)1.09%
Max Revenue beat(4)5.12%
Revenue beat(8)5
Avg Revenue beat(8)1.17%
Revenue beat(12)6
Avg Revenue beat(12)0.55%
Revenue beat(16)8
Avg Revenue beat(16)0.31%
PT rev (1m)1.55%
PT rev (3m)2.26%
EPS NQ rev (1m)3.15%
EPS NQ rev (3m)3.5%
EPS NY rev (1m)5.63%
EPS NY rev (3m)9.92%
Revenue NQ rev (1m)1.61%
Revenue NQ rev (3m)1.8%
Revenue NY rev (1m)1.17%
Revenue NY rev (3m)2.65%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 61.93 | ||
| Fwd PE | 53.92 | ||
| P/S | 19.89 | ||
| P/FCF | 84.18 | ||
| P/OCF | 64.58 | ||
| P/B | 11.22 | ||
| P/tB | 11.45 | ||
| EV/EBITDA | 52.99 |
EPS(TTM)7.45
EY1.61%
EPS(NY)8.56
Fwd EY1.85%
FCF(TTM)5.48
FCFY1.19%
OCF(TTM)7.14
OCFY1.55%
SpS23.19
BVpS41.12
TBVpS40.28
PEG (NY)3.11
PEG (5Y)5.39
Graham Number83.02
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 14.19% | ||
| ROE | 16.12% | ||
| ROCE | 16.61% | ||
| ROIC | 12.45% | ||
| ROICexc | 24.65% | ||
| ROICexgc | 25.69% | ||
| OM | 29.44% | ||
| PM (TTM) | 28.58% | ||
| GM | 66.38% | ||
| FCFM | 23.63% |
ROA(3y)11.41%
ROA(5y)11.26%
ROE(3y)13.21%
ROE(5y)12.97%
ROIC(3y)10.15%
ROIC(5y)9.87%
ROICexc(3y)15.35%
ROICexc(5y)15.85%
ROICexgc(3y)16.06%
ROICexgc(5y)16.75%
ROCE(3y)13.54%
ROCE(5y)13.16%
ROICexgc growth 3Y-7.59%
ROICexgc growth 5Y-7%
ROICexc growth 3Y-6.87%
ROICexc growth 5Y-6.06%
OM growth 3Y-4.19%
OM growth 5Y-1.68%
PM growth 3Y-2.34%
PM growth 5Y-2.02%
GM growth 3Y-0.91%
GM growth 5Y-0.58%
F-Score8
Asset Turnover0.5
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 111.36% | ||
| Cap/Sales | 7.17% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 85.84% | ||
| Profit Quality | 82.69% | ||
| Current Ratio | 4.97 | ||
| Quick Ratio | 4.2 | ||
| Altman-Z | N/A |
F-Score8
WACC8.75%
ROIC/WACC1.42
Cap/Depr(3y)197.35%
Cap/Depr(5y)162.98%
Cap/Sales(3y)12.27%
Cap/Sales(5y)10.16%
Profit Quality(3y)56.77%
Profit Quality(5y)75.99%
High Growth Momentum
Growth
EPS 1Y (TTM)28.12%
EPS 3Y13.83%
EPS 5Y11.48%
EPS Q2Q%30.43%
EPS Next Y19.93%
EPS Next 2Y16.17%
EPS Next 3Y15.85%
EPS Next 5Y15.47%
Revenue 1Y (TTM)22.18%
Revenue growth 3Y13.51%
Revenue growth 5Y13.27%
Sales Q2Q%22.91%
Revenue Next Year21.17%
Revenue Next 2Y18.1%
Revenue Next 3Y16.53%
Revenue Next 5Y14.12%
EBIT growth 1Y36.82%
EBIT growth 3Y8.76%
EBIT growth 5Y11.37%
EBIT Next Year40.01%
EBIT Next 3Y23.66%
EBIT Next 5Y20.46%
FCF growth 1Y80.69%
FCF growth 3Y-9.1%
FCF growth 5Y2.14%
OCF growth 1Y46.32%
OCF growth 3Y4.95%
OCF growth 5Y8.61%
INTUITIVE SURGICAL INC / 1ISRG.MI FAQ
Can you provide the ChartMill fundamental rating for INTUITIVE SURGICAL INC?
ChartMill assigns a fundamental rating of 7 / 10 to 1ISRG.MI.
Can you provide the valuation status for INTUITIVE SURGICAL INC?
ChartMill assigns a valuation rating of 2 / 10 to INTUITIVE SURGICAL INC (1ISRG.MI). This can be considered as Overvalued.
Can you provide the profitability details for INTUITIVE SURGICAL INC?
INTUITIVE SURGICAL INC (1ISRG.MI) has a profitability rating of 8 / 10.
What are the PE and PB ratios of INTUITIVE SURGICAL INC (1ISRG.MI) stock?
The Price/Earnings (PE) ratio for INTUITIVE SURGICAL INC (1ISRG.MI) is 61.93 and the Price/Book (PB) ratio is 11.22.
What is the expected EPS growth for INTUITIVE SURGICAL INC (1ISRG.MI) stock?
The Earnings per Share (EPS) of INTUITIVE SURGICAL INC (1ISRG.MI) is expected to grow by 19.93% in the next year.